Skip to main content
. 2023 Dec 19;18(12):e0295741. doi: 10.1371/journal.pone.0295741

Fig 4.

Fig 4

RMSF of residues in AURKA and AURKB during MD simulations: (A) RMSF for apo AURKA and its complexes with HPM, MPY, and VX6, (B) the structure of AURKA, (C) RMSF of apo AURKB and its complexes with three inhibitors and (D) the structure of AURKB.